Shopping Cart 0
Cart Subtotal
USD 0

Sanford Burnham Prebys Medical Discovery Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sanford Burnham Prebys Medical Discovery Institute (SBP) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment and cancer immunology, degenerative diseases, immunity and pathogenesis, human genetics development, aging and regeneration, bioinformatics and structural biology, cardiovascular metabolism, integrative metabolism, and genomic control of metabolism. It offers stem cell research and drug discovery technologies. SBP also offers educational services such as postdoctoral training, graduate school and international services. The institute's technology centers include conrad prebys center for chemical genomics, stem cell research center and translational research institute, among others. It operates through its offices in La Jolla and Orlando, the US. SBP is headquartered in La Jolla, California, the US.

Sanford Burnham Prebys Medical Discovery Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Takeda Pharma Enters into Agreement with Sanford-Burnham 11

Eli Lilly Enters into Research Agreement with Sanford Burnham 12

Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13

Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14

Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15

Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16

Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17

Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 19

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 20

Licensing Agreements 22

Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22

Clementia Pharma Enters Into License Agreement With Sanford Burnham Prebys Medical 23

DrugCendR Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24

Sanford Burnham Prebys Medical Discovery Institute-Key Competitors 25

Sanford Burnham Prebys Medical Discovery Institute-Key Employees 26

Sanford Burnham Prebys Medical Discovery Institute-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Government and Public Interest 28

Sep 26, 2017: SBP scientist receives USD 10.8 million grant to advance potential drug for substance abuse 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Key Facts 2

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sanford Burnham Prebys Medical Discovery Institute, Deals By Therapy Area, 2012 to YTD 2018 8

Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Takeda Pharma Enters into Agreement with Sanford-Burnham 11

Eli Lilly Enters into Research Agreement with Sanford Burnham 12

Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13

Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14

Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15

Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16

Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17

Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 19

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 20

Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22

Clementia Pharma Enters Into License Agreement With Sanford Burnham Prebys Medical 23

DrugCendR Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24

Sanford Burnham Prebys Medical Discovery Institute, Key Competitors 25

Sanford Burnham Prebys Medical Discovery Institute, Key Employees 26

Sanford Burnham Prebys Medical Discovery Institute, Other Locations 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sanford Burnham Prebys Medical Discovery Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.